NasdaqGM:AVDLPharmaceuticals
Is Avadel Pharmaceuticals Still Attractive After a 113.4% One Year Surge in 2025?
If you are wondering whether Avadel Pharmaceuticals at around $21 a share still has room to run or is already priced for perfection, you are not alone. This breakdown is designed to give you a clear, valuation focused view.
The stock has dipped about 0.7% over the last week, but it is still up 12.6% over the past month and 94.0% year to date, with a 113.4% gain over the last year shifting how the market thinks about its risk and reward profile.
Much of that surge has been driven by growing...